Apr 14, 2023 by James HalleyWhy Shares of Sana Biotechnology Jumped This WeekThe company announced details of research on two of its pre-clinical therapies.
Apr 13, 2023 by James HalleyWhy Inovio Pharmaceuticals' Shares Jumped on ThursdayThe company will present an abstract for its Ebola vaccine booster this month.
Apr 13, 2023 by James HalleyWhy Shares of CRISPR Therapeutics Jumped ThursdayAn independent drug-pricing group said that a $1.9 million cost for the company's exa-cel therapy would be cost-effective.
Apr 13, 2023 by James HalleyProceed With Caution When Considering These 5 Ultra-Popular StocksFour of these five stocks are losing money.
Apr 12, 2023 by James HalleyCould Gilead Sciences Stock Help You Become a Millionaire?The company's dominant HIV therapies and growing oncology pipeline are delivering.
Apr 11, 2023 by James HalleyWhy Shares of Shockwave Medical Jumped on TuesdayThe proposed new payment structure by the CMS would help Shockwave's business.
Apr 11, 2023 by James HalleyWhy Shares of TG Therapeutics Soared on TuesdayEarly reports of strong sales for its recently approved multiple sclerosis drug gave the stock a jolt.
Apr 11, 2023 by James HalleyWhy Shares of Adaptimmune Therapeutics Jumped TuesdayThe company bulks up its pipeline by regaining the rights to two of its clinical programs.
Apr 8, 2023 by James HalleyHere's Why Pfizer Will Bounce Back This YearThe company has used its COVID-19 therapy and vaccine profits to beef up its pipeline.
Apr 6, 2023 by James HalleyWhy BeiGene Stock Jumped ThursdayA collaboration deal helped send the Chinese biotech stock higher.
Apr 6, 2023 by James HalleyWhy Shares of Apollomics Soared in MarchThe company's shares jumped after it went public via a SPAC merger at the end of the month.
Apr 6, 2023 by James HalleyWhy Shares of Heron Therapeutics Jumped ThursdayThe stock has been rising since the company appointed a new CEO.
Apr 6, 2023 by James Halley3 No-Brainer Medical Device Stocks to Buy Right NowThese companies have consistently delivered revenue and EPS gains.
Apr 5, 2023 by James HalleyWhy Shares of MorphoSys Are Up WednesdayThe company's phase 3 trial for a lead therapy is ahead of schedule.
Apr 5, 2023 by James HalleyWhy Shares of InflaRx Are Soaring WednesdayA key EUA from the FDA for the company's COVID-19 therapy gave the stock a jolt.
Apr 5, 2023 by James HalleyBest Pharmacy Stock to Buy Right NowPharmacy stocks can be solid long-term buys -- if you pick the right one.
Apr 5, 2023 by James HalleyMedical Properties Trust: Is It Safe to Buy the Dip?Its 14% dividend yield is tempting, but is it safe?
Apr 4, 2023 by James HalleyWhy Shares of Encompass Health Soared TuesdayA proposed payment increase by Medicare drove shares of the rehabilitation-hospital operator higher.
Apr 4, 2023 by James HalleyWhy Shares of Inovio Pharmaceuticals Were Down TuesdayThe biotech stock, still reeling from a failed clinical trial, hit a 52-week low.
Apr 4, 2023 by James Halley3 Top Healthcare Stocks to Buy for AprilThese pharmaceutical companies' shares are down, but their prospects are rising.
